Meropenem.
Copyright policy )Meropenem.
Meropenem is a new carbapenem antibacterial agent with wide spectrum of activity against gram-negative, gram-positive and anaerobic organisms. It is stable against most beta-lactamases produced by gram-negative bacteria and has greatest utility in treating severe infections in hospitalized children. It has good CSF penetrability and useful in treatment of childhood meningitis and infections in neutropenic children. Due to concern relating to emergence of resistance, it should be used as a reserve drug in difficult-to-treat infections caused by resistant organisms or when conventional treatment fails.
Neutropenia, Infant, Newborn, Infant, Bacterial Infections, Meropenem, Intensive Care Units, Central Nervous System Bacterial Infections, Child, Preschool, Drug Resistance, Bacterial, Humans, Thienamycins, Child
Neutropenia, Infant, Newborn, Infant, Bacterial Infections, Meropenem, Intensive Care Units, Central Nervous System Bacterial Infections, Child, Preschool, Drug Resistance, Bacterial, Humans, Thienamycins, Child
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!